Synthesis of new 3-(substituted phenacyl)-5-[3′-(4H-4-oxo-1- benzopyran-2-yl)-benzylidene]-2,4-thiazolidinediones and their antimicrobial activity

Archiv der Pharmazie

Volumn 339, Issue 4, 2006, Pages 213-216

  Tuncbilek, Meral ^a   Altanlar, Nurten ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Antibacterial activity; Antifungal activity; Flavonyl thiazolidinediones; Phenacyl thiazolidine 2,4 diones

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 3 (2,5 DIMETHOXYPHENACYL) 5 [3' (4H 4 OXO 1 BENZOPYRAN 2 YL)BENZYLIDENE] 2,4 THIAZOLIDINEDIONE; 3 (3 NITROPHENACYL) 5 [3' (4H 4 OXO 1 BENZOPYRAN 2 YL)BENZYLIDENE] 2,4 THIAZOLIDINEDIONE; 3 (3 NITROPHENACYL)THIAZOLIDINE 2,4 DIONE; 3 (4 CHLOROPHENACYL) 5 [3' (4H 4 OXO 1 BENZOPYRAN 2 YL)BENZYLIDENE] 2,4 THIAZOLIDINEDIONE; 3 (4 FLUOROPHENZCYL) 5 [3' (4H 4 OXO 1 BENZOPYRAN 2 YL)BENZYLIDINE] 2,4 THIAZOLIDINEDIONE; 3 (4 METHOXYPHENACYL) 5 [3' (4H 4 OXO 1 BENZOPYRAN 2 YL)BENZYLIDENE] 2,4 THIAZOLIDINEDIONE; 3 (4 NITROPHENAZYL) 5 [3' (4H 4 OXO 1 BENZOPYRAN 2 YL)BENZYLIDENE] 2,4 THIAZOLIDINEDIONE; 3 PHENACYL 5 [3' (4H 4 OXO 1 BENZOPYRAN 2 YL)BENZYLIDENE] 2,4 THIAZOLIDINEDIONE; ALDEHYDE; FLAVONE DERIVATIVE; FLUCONAZOLE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED RADIATION; KNOEVENAGEL CONDENSATION; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; CANDIDA ALBICANS; CANDIDA GLABRATA; FLUCONAZOLE; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLIDINEDIONES;

EID: 33646125174     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200500180     Document Type: Article

References (20)

1. F. C. Tenover, Clin. Infect. Dis. 2001, 15, 108-115.
2. R. J. Williams, Clin. Infect. Dis. 2001, 15, 116-117.
3. M. B. Edmond, S. E. Wallace, D. K. McClish, M. A. Pfaller, R. N. Jones, R. P. Wenzel, Clin. Infect. Dis. 1999, 29, 239-244.
4. J. R. Rees, R. W. Pinner, R. A. Hajjeh, M. E. Brandt, A. L. Reingold, Clin. Infect. Dis. 1998, 27, 1138-1147.
5. F. C. Brown, Chem. Rev. 1961, 61, 463-521.
6. S. P. Singh, S. S. Parmar, K. Raman, V. I. Stenberg, Chem. Rev. 1981, 81, 175-203.
7. A. S. Samarin, V. A. Loskutov, Chem. Abstr. 1965, 63, 595C.
8. J. V. Mandlik, V. A. Patwardham, K. S. Nargund, Chem. Abstr. 1968, 69, 27309u.
9. A. J. S. Goes, M. C. A. De Lima, S. L. Galdino, I. D. Pitta, C. Duu-Luc, Ann. Pharm. Fr. 1991, 49, 92-98.
10. M. C. A. Lima, D. L. B. Costa, A. J. S. Goes, I. R. Pitta, C. Duu-Luc, Pharmazie 1992, 47, 182-184.
11. G. Ayhan-Kilcigil, N. Altanlar, Arzneim.-Fors./Drug Res. 2000, 50, 154-157.
12. M. Tuncbilek, N. Altanlar, Il Farmaco 1999, 54, 475-478.
13. S. F. Tan, K. P. Ang, Y. F. Fong, J. Chem. Soc. Perkin Trans. II 1986, 12, 1941-1944.
14. U. Vögeli, W. Philipsborn, Helv. Chim. Acta 1978, 61, 607-617.
15. F. C. Albuquerque, A. Albuquerque, C. C. Azevedo, F. Thomasson, L. S. Galdino, J. Chantegrel, M. T. Catanho, I. R. Pitta, C. Luu-Duc, Pharmazie 1995, 50, 387-389.
16. H. M. Salama, I. M. Labouta, M. A. Moustafa, Alex. J. Pharm. Sci. 1990, 4, 44-46.
17. J. G. De Lima, M. Perrissin, J. Chantegrel, C. Luu-Duc, A. Rousseau, G. Narcisse, Arzneim.-Fors./Drug Res. 1994, 44, 831-834.
18. M. Tuncbilek, R. Ertan, Pharmazie 1999, 54, 255-259.
19. NCCLS, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard M27-A, National Committee on Clinical Laboratory Standards 1997, 17, 9.
20. NCCLS, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically M7-A5, National Committee on Clinical Laboratory Standards 2000, 20, 2.